isolate CTCs
cancer therapy
identification of CTCs
treatment of cancer patients
white blood cells
Circulating Tumour Cells
rarity of tumour cells
peripheral blood
millilitre of blood
metastatic breast cancer
aggressiveness of metastatic cancer
alternative methods of CTCs enumeration
anomalous metabolic properties of tumour cells
potential clinical benefits of CTC analysis
new method
speed of analysis
FDA-approved CTC enumeration system
NOvel METAbolic liquid biopsy
early-stage
strong evidence
strong indicators
chosen treatment
novel means
tremendous effect
risk of relapse
state-of-the-art method
potential impact
Cytofind Diagnostics
disruptive technology
early screening of individuals
promising therapy options
certain risk groups
so-called Warburg effect
single cell determination
different parts
reliable prognostic factor
CellSearch
oncology care cycle
detection
cost-effective way
characterization
Feasibility study
market
urgent need
ability
estimates
significant efforts
introduction
severe limitations
key technical challenge